INTRINSIC MOLECULAR SUBTYPES, CSCS STATES AND HER2+ BC: RETHINKING THE PROGNOSTIC-PREDICTIVE VALUE OF CHER2+ TUMORS. This evidence concerns the gene ERBB2 and breast cancer.